PTI Protherics

    RNS Number : 4907H
  BTG PLC
  05 November 2008
   

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO THE SAME WOULD
CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

    London, 5 November 2008

    BTG PLC ("BTG")

    Offer Update: Result of Shareholder Meeting

    The BTG Board is pleased to announce that, at the BTG Extraordinary General Meeting (the "Shareholder Meeting") held earlier today in
relation to the recommended offer for Protherics PLC ("Protherics") by BTG (the "Proposed Acquisition"), the Proposed Acquisition received
the overwhelming support of BTG Shareholders, and the resolutions necessary to approve the Proposed Acquisition were passed by the requisite
majorities.



    The number of proxy votes lodged for each resolution before the meeting was as follows:

                                         Total For*                Total Against         Votes Withheld
 Resolution                      No. of votes  %age of vote  No. of votes  %age of vote    No. of votes
 1. To approve the acquisition     98,766,102         99.88        82,564          0.08         299,464
 of Protherics PLC
 2. To allot equity securities     99,042,951         99.87        85,042          0.09          14,693
 for cash

     *Figures do not include discretionary votes.

    Implementation of the Scheme of Arrangement remains conditional upon the approval by Protherics Shareholders of the Protherics
Resolutions at the Protherics EGM and of the Scheme at the Court Meeting, both of which are due to be held on 11 November 2008, and the
satisfaction or (where applicable) waiver of the other Conditions set out in the Scheme Document posted to Protherics Shareholders on 17
October 2008.

    On the basis that the Protherics Resolutions are passed and that the Court sanctions the Scheme at the Court hearing scheduled to take
place on 1 December and confirms the associated Reduction of Capital at the Reduction Court Hearing scheduled to take place on 3 December
2008, it is anticipated that, on 4 December 2008, the Scheme will become effective and dealings in the New BTG Shares will commence. New BTG
Shares will be credited to CREST accounts on the same date. It is expected that share certificates for New BTG Shares will be dispatched by
no later than 18 December 2008.

    Copies of the BTG Resolutions passed at the Shareholder Meeting will be available for inspection by the public from tomorrow at the
offices of BTG at 10 Fleet Place Limeburner Lane London EC4M 7SB and also those of Allen & Overy LLP situated at: One Bishops Square, London
E1 6AD (tel. no. +44 (0)20 3088 0000) during normal business hours on any weekday (public holidays excepted) until 4 December 2008. 

    Terms used but not defined in this announcement shall have the same meaning as in the Prospectus Equivalent Document dated 17 October
2008 which was sent to BTG Shareholders and Protherics Shareholders.

    Enquiries 

 BTG
 Christine Soden, Chief Financial Officer         Tel: 020 7575 0000
 Andy Burrows, Director of Investor Relations

 Protherics 
 Dr Andrew Heath, Chief Executive Officer         Tel: 020 7246 9950
 Rolf Soderstrom, Chief Financial Officer

 Rothschild (financial adviser to BTG)
 Dr Lynn Drummond                                 Tel: 020 7280 5000

 Jefferies (financial adviser to Protherics)
 Ian Crosbie                                      Tel: 020 7029 8000
 Chris Snoxall (corporate broking)

 Piper Jaffray (joint broker and adviser to BTG)
 Neil Mackison / Jamie Adams                      Tel: 020 3142 8700

 Credit Suisse (joint broker and adviser to BTG)
 Stephanie Leouzon / Tristan Lovegrove            Tel: 020 7888 8000

 Nomura Code Securities (broker to Protherics)
 Chris Collins                                    Tel: 020 7776 1200

 Financial Dynamics
 Ben Atwell                                       Tel: 020 7831 3113

    Rothschild, which is authorised and regulated in the UK by the Financial Services Authority, is acting as financial adviser and sponsor
to BTG in connection with the Recommended Offer and no-one else and will not be responsible to anyone other than BTG for providing the
protections afforded to clients of Rothschild nor for providing advice in relation to the Acquisition nor any other matter referred to in
this announcement.

    Jefferies, which is authorised and regulated in the UK by the Financial Services Authority, is acting as financial adviser and broker to
Protherics in connection with the Recommended Offer and no-one else and will not be responsible to anyone other than Protherics for
providing the protections afforded to clients of Jefferies nor for providing advice in relation to the Acquisition nor any other matter
referred to in this announcement.


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
REGBABMTMMAMBMP

Protherics (LSE:PTI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Protherics (LSE:PTI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024